Changes to the website
Sponsored By
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4891

Next 25
Website Changes
12/03/2019 SNO 2019: The Oncolytic Herpes Virus G47? May Lead to a Potential Cure of Malignant Glioma
12/03/2019 Musella Foundation`s Annual Giving Campaign
12/01/2019 New Italian version of our Brain Tumor Guide for the Newly Diagnosed!
11/28/2019 New videos added to
11/25/2019 SNO 2019: The Oncolytic Herpes Virus G47? May Lead to a Potential Cure of Malignant Glioma
11/25/2019 DNAtrix Presents Positive Results from the Phase 2 CAPTIVE/KEYNOTE-192 Study of DNX-2401 in Combination with Pembrolizumab for Glioblastoma at the 2019 SNO Annual Meeting
11/25/2019 The Conversation
11/25/2019 Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology
11/25/2019 Val-083 for unmethylated GBM
11/19/2019 Publication in Nature Communications Confirms DRD2 as Target of ONC201
11/18/2019 Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.
11/18/2019 Another paid survey!
11/13/2019 Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
10/27/2019 Musella Foundation Online Support Groups are moving!
10/26/2019 NYU Langone Health launches new molecular assay to identify patients with brain tumors
10/24/2019 GBM patient and Caregiver Survey
10/22/2019 Donate or request expensive medicines!
10/10/2019 Oncology Pioneer xCures Names Experts to Advisory Boards
10/10/2019 New Trial of Focused Ultrasound in Glioblastoma: Opening the Blood-Brain Barrier for Chemotherapy
10/10/2019 First-line treatment of ONC 201 in newly diagnosed DIPG pediatric patients is now open.
10/09/2019 Any Amazon users?
09/30/2019 Optune Open House
09/27/2019 Barriers to accrual and enrollment in brain tumor trials
09/25/2019 Medicenna Presents Promising Update from its MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557